Levonorgestrel
- PDF / 169,500 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 88 Downloads / 132 Views
1
Levonorgestrel Various toxicities: 2 case reports In a retrospective audit of 20 women, who attended an integrated sexual health service for levonorgestrel intrauterine system (IUS) insertion in 2016–2017, 2 women [exact ages at the time of reactions onsets not stated] were described, who developed bleeding, low mood, occasional abdominal discomfort or spotting during treatment with levonorgestrel for contraception. The women underwent intrauterine insertion of levonorgestrel IUS [Jaydess] 13.5mg for contraception. However, one woman developed bleeding secondary to levonorgestrel and requested IUS reinsertion. The other woman developed low mood, spotting and occasional abdominal discomfort and requested IUS removal 3 months after IUS insertion [duration of treatments to reactions onset and outcomes not stated]. Author comment: "It is important to provide patients with information regarding potential risk of developing low mood or/and depression with progesterone only contraception." "[O]ne patient requested IUS reinsertion after having bleeding problems with [levonorgestrel]." Matytsina-Quinlan LA. Jaydess audit standards and benefits. BMJ Sexual and Reproductive Health 45: 314-315, No. 4, Oct 2019. Available from: URL: http:// 803434962 doi.org/10.1136/bmjsrh-2019-200308 - United Kingdom
0114-9954/19/1780-0001/$14.95 Adis © 2019 Springer Nature Switzerland AG. All rights reserved
Reactions 23 Nov 2019 No. 1780
Data Loading...
